Ensysce Biosciences
Ensysce Biosciences, Inc.(NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
13
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
3
tools in use
Monthly traffic
166
organic / mo
Sign up free to see all 5 verified contacts at Ensysce Biosciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- GB
Geoff Birkett
Chief Commercial Officer · Sales & Business Development
EmailPhone - LP
Linda Pestano
Chief Development Officer · General Business & Management
EmailPhone - DH
Dave Humphrey
Chief Financial Officer · Other
EmailPhone
Showing 3 of 5 verified contacts
Top roles at Ensysce Biosciences
4 distinct titles indexed · top 4 shown.
- 1chief commercial officer
- 1chief development officer
- 1chief development officer (cdo)
- 1chief financial officer
Sign up to unlock all 5 contacts at Ensysce Biosciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Ensysce Biosciences
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.